Could 4 months of meds be enough? new trial aims to shorten CMV treatment for newborns
NCT ID NCT07450365
First seen Mar 04, 2026 · Last updated May 06, 2026 · Updated 7 times
Summary
This study looks at whether giving antiviral medicine for 4 months instead of the usual 6 months works just as well for babies born with a serious viral infection called congenital CMV. The infection can cause hearing loss and developmental delays. The trial will enroll 150 newborns and follow them for two years to compare brain development, hearing, and overall health between the two treatment lengths. The goal is to find a shorter, effective treatment that is easier for families.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL CMV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.